Clopidogrel and Tarceva drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Clopidogrel (clopidogrel) and Tarceva (erlotinib hydrochloride). Common drug interactions include epistaxis among females and rash among males.
The phase IV clinical study analyzes what interactions people have when they take Clopidogrel and Tarceva. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
What is Tarceva?
Tarceva has active ingredients of erlotinib hydrochloride. It is often used in lung cancer. eHealthMe is studying from 31,036 Tarceva users. Check the latest studies of Tarceva.
73 people who take Clopidogrel and Tarceva together, and have interactions are studied.
What are the common drug interactions of Clopidogrel and Tarceva, by gender? *:
female:
- Epistaxis (bleed from the nose)
- Pneumonia
- Stomatitis (inflammation of mucous membrane of mouth)
- Decreased appetite
- Eye discharge
- Eye infection
- Eyelid oedema (eyelids are swollen and contain excessive fluid)
- Pulmonary mass
- Abdominal distension
- Anaemia (lack of blood)
male:
- Rash
- Diarrhoea
- Acne (skin problems that cause pimples)
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
- Cardiac failure
- Cytomegalovirus infection
- Interstitial lung disease
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Abdominal discomfort
- Anxiety
What are the common drug interactions of Clopidogrel and Tarceva, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Death
- Back pain
- Colitis (inflammation of colon)
- Disease progression
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Hospitalisation
- Myalgia (muscle pain)
- Pericardial effusion (fluid around the heart)
- Pleural effusion (water on the lungs)
- Sigmoiditis (inflammation of the sigmoid colon)
60+:
- Rash
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
- Cardiac failure
- Cytomegalovirus infection
- Interstitial lung disease
- Pneumonia
- Chest discomfort
- Chest pain
What are the existing conditions these people have? *
- Lung Neoplasm Malignant (cancer tumour of lung): 52 people, 71.23%
- Lung Cancer - Non-Small Cell (lung cancer): 4 people, 5.48%
* Approximation only. Some reports may have incomplete information.
Do you take Clopidogrel and Tarceva?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Clopidogrel (92,160 reports)
- Tarceva (31,036 reports)
Browse all drug interactions of Clopidogrel and Tarceva:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tarceva:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clopidogrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tarceva and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on clopidogrel and erlotinib hydrochloride (the active ingredients of Clopidogrel and Tarceva, respectively), and Clopidogrel and Tarceva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cymbalta cause Pulmonary Oedema Aggravated? - 8 seconds ago
- Drug interactions of Clobetasol Propionate and Asacol - 14 seconds ago
- Drug interactions of Clobetasol Propionate and Amoxicillin - 17 seconds ago
- Rheumatoid Arthritis and Back Pain - 30 seconds ago
- Drug interactions of Augmentin and Co-Codamol - 51 seconds ago
- Could Profen cause Cd4 Lymphocytes Increased? - 52 seconds ago
- How effective is Adalat for Raynaud'S Phenomenon? - a minute ago
- Drug interactions of Tyrosine and Lexapro - a minute ago
- Rheumatoid Arthritis and Malabsorption - a minute ago
- Could Flonase cause Chest Pain? - a minute ago